CHLD
CHANGE OF OWNER RECEIVED FROM IB
19/02/2026
Voltar para busca
Dado oficial do USPTO
NP
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
30
Atualização mais recente
21/02/2026
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
5, 9, 10, 42, 44
Data de depósito
09/11/2018
Data de registro
18/02/2020
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
18/02/2020
Última transação
21/02/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
5
Tipo de titular
98
Localização do titular
NL
Examinador
JOHNSON, AISHA CLARKE
Unidade examinadora
L10
Localização atual
PUBLICATION AND ISSUE SECTION
Descrição da marca
The mark consists of the blue stylized letters "NP" where these letters are connected with a shared vertical stem.
Titulares e representantes
Titulares
Pharming Intellectual Property B.V.
Abliva AB
NeuroVive Pharmaceutical AB
Representantes
Paul F. Kilmer HOLLAND & KNIGHT LLP
Classificação técnica
Classes Nice
Classe 5Classe 9Classe 10Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Acetates for pharmaceutical purposes; acids for pharmaceutical purposes; adjuvants for medical purposes; aldehydes for pharmaceutical purposes; alginates for pharmaceutical purposes; amino acids for medical purposes; amino acids for veterinary purposes; antibiotics; antidiabetic pharmaceuticals; food supplementsantioxidant pills; food supplementsantioxidants; antitumor drugs in the nature of tumor suppressing agents; appetite suppressant pills; appetite suppressants; appetite suppressants for medical purposes; appetite suppressants for veterinary purposes; bacterial preparations for medical use; bacterial preparations for veterinary use; bacteriological culture mediums; bacteriological preparations for medical purposes; bacteriological preparations for medical use; bacteriological preparations for veterinary purposes; bacteriological preparations for veterinary use; biological preparations for medical purposes for the treatment of metabolicneurologicalcardiovascular and musculoskeletal diseasescancerdiabetesNASHmitochondrial diseases and rare diseases; biological preparations for the treatment of cancer; biological tissue cultures for medical purposes; biological tissue cultures for veterinary purposes; biological tissues for implantation being implants comprising living tissue; bouillons for bacteriological cultures; cachets being capsules sold empty for pharmaceutical preparations; capsules sold empty for pharmaceutical preparations; castor oil for medical purposes; cellulose ethers for pharmaceutical purposes; chemical preparations for medical purposesfor metabolicneurologicalcardiovascular and musculoskeletal diseasescancerdiabetesNASHmitochondrial diseases and rare diseases; chemical preparations for pharmaceutical purposesfor metabolicneurologicalcardiovascular and musculoskeletal diseasescancerdiabetesNASHmitochondrial diseases and rare diseases; chemicopharmaceutical preparations for metabolicneurologicalcardiovascular and musculoskeletal diseasescancerdiabetesNASHmitochondrial diseases and rare diseases; cytostatic drugs for medical purposes; decoctions for pharmaceutical purposesfor the treatment of metabolicneurologicalcardiovascular and musculoskeletal diseasescancerdiabetesNASHmitochondrial diseases and rare diseases; dental wax; diagnostic biomarker reagents for medical purposes; diagnostic biomarker reagents for veterinary purposes; diagnostic preparations for medical and veterinary use; diagnostic preparations for medical use; diagnostic preparations for veterinary use; diagnostic preparations for medical purposes; diagnostic preparations for veterinary purposes; diagnostic radiopharmaceutical preparations; dietary supplements for animals; dietary supplements for humans; dietetic food and substances adapted for medical or veterinary usefood for human and animal babies; dietetic food and substances adapted for medical or veterinary use; dietetic substances adapted for medical usefood for babies; digestive enzymes being dietary supplements; disinfectants; drugs for medical purposes in the nature of medical preparations for metabolicneurologicalcardiovascular and musculoskeletal diseasescancerdiabetesNASHmitochondrial diseases and rare diseases; pharmaceutical preparationselixirs for the treatment of metabolicneurologicalcardiovascular and musculoskeletal diseasescancerdiabetesNASHmitochondrial diseases and rare diseases; enzyme dietary supplements; enzyme preparations for medical purposes; enzyme preparations for veterinary purposes; enzymes for medical purposes; enzymes for veterinary purposes; esters for pharmaceutical use; ethers for pharmaceutical purposes; ferments for pharmaceutical purposes; ferments for pharmaceutical use; ferments for veterinary purposes; ferments for veterinary use; food esters for pharmaceutical purposes; formic aldehyde for pharmaceutical purposes; formic aldehyde for veterinary purposes; fungicidesherbicides; in vitro diagnostic preparations for medical use; skin lotions for medical purposes; skin lotions for pharmaceutical purposes; material for stopping teeth; material for stopping teethdental wax; media for bacteriological cultures; medical and veterinary preparations and products for metabolicneurologicalcardiovascular and musculoskeletal diseasescancerdiabetesNASHmitochondrial diseases and rare diseases; medical preparations for metabolicneurologicalcardiovascular and musculoskeletal diseasescancerdiabetesNASHmitochondrial diseases and rare diseases; medical preparations for slimming purposes; medical vaccines; medicated animal feed; medicinal drinks; medicinal infusions for treating metabolicneurologicalcardiovascular and musculoskeletal diseasescancerdiabetesNASHmitochondrial diseases and rare diseases; medicinal oils; medicines and pharmaceutical preparations for neurosurgical conditionsbrain damageneurological operations; medicines and pharmaceutical preparations for neurosurgical conditionsbrain damage and brain operations; medicines and pharmaceutical preparations for the treatment of neurosurgical conditionsbrain damagebrain operationsother physical and neurological ailments of the brain; medicines and pharmaceutical preparations for the treatment of neurosurgical conditionsfor brain damage and for use in brain operations and other physical and neurological ailments of the brain; medicines and pharmaceutical preparations for use as immunosuppressive agents; medicines and pharmaceutical preparations for use as immunosuppressive agents in organ transplants or other medical and clinical uses of immunosuppressive agents; medicines and pharmaceutical preparations for use as immunosuppressive agents for organ transplants; medicines and pharmaceutical preparations for neurological conditions within the area of neurological intensive care; medicines for human purposes in the nature of medicinal preparations for metabolicneurologicalcardiovascular and musculoskeletal diseasescancerdiabetesNASHmitochondrial diseases and rare diseases; mixed biological preparations for medical purposesfor the treatment of metabolicneurologicalcardiovascular and musculoskeletal diseasescancerdiabetesNASHmitochondrial diseases and rare diseases; nutritional supplements; nutritional supplements for livestock feed; medicated ointments for medical purposesfor treating dermatological conditions; pharmaceutical and veterinary preparations for metabolicneurologicalcardiovascular and musculoskeletal diseasescancerdiabetesNASHmitochondrial diseases and rare diseases; pharmaceutical and veterinary preparationsmedicines and pharmaceutical preparations for the treatment and prevention of acute and chronic neurological illnesses and conditions; pharmaceutical and veterinary preparationsmedicines and pharmaceutical preparations for acute and chronic neurological illnesses and conditions and for preventative treatment; pharmaceutical drugs in the nature of pharmaceutical preparations for metabolicneurologicalcardiovascular and musculoskeletal diseasescancerdiabetesNASHmitochondrial diseases and rare diseases; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and other preparations for destroying vermin; fungicides and herbicides; pharmaceutical preparations and substances for metabolicneurologicalcardiovascular and musculoskeletal diseasescancerdiabetesNASHmitochondrial diseases and rare diseases; pharmaceutical preparations and substances for the prevention of cancer; pharmaceutical preparations and substances for the treatment of cancer; pharmaceutical preparations and substances for use in oncology; pharmaceutical preparations for activating cellular function; pharmaceutical preparations for human use for metabolicneurologicalcardiovascular and musculoskeletal diseasescancerdiabetesNASHmitochondrial diseases and rare diseases; pharmaceutical preparations for medical purposes and veterinary purposesfor metabolicneurologicalcardiovascular and musculoskeletal diseasescancerdiabetesNASHmitochondrial diseases and rare diseases; pharmaceutical preparations for medical use consisting of a cyclosporin as active agent and diluents to treat stroketraumatic brain or spinal cord injuryother acute or chronic neurological and neurosurgical conditions; pharmaceutical preparations for medical use consisting of a cyclosporin or another cyclophilin inhibitor as active agent and diluents to treat stroketraumatic brain or spinal cord injuryother acute or chronic neurological and neurosurgical conditions; pharmaceutical preparations for skin care; pharmaceutical preparations for suppressing tumors; pharmaceutical preparations for the prevention of diseases of the nervous system; pharmaceutical preparations for the prevention of diseases of the metabolic system; pharmaceutical preparations for the prevention of disorders of the metabolic system; pharmaceutical preparations for the prevention of disorders of the nervous system; pharmaceutical preparations for the prevention of tumors; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of central nervous system diseases; pharmaceutical preparations for the treatment of diseases caused by bacteria in the nature of antibacterial pharmaceuticals; pharmaceutical preparations for the treatment of diseases of the metabolic system; pharmaceutical preparations for the treatment of disorders of the metabolic system; pharmaceutical preparations for the treatment of kidney diseases; pharmaceutical preparations for the treatment of kidney disorders; pharmaceutical preparations for the treatment of Parkinson's disease; pharmaceutical preparations for the treatment of tumors; pharmaceutical preparations for the treatment of viral diseases in the nature of antivirals; pharmaceutical preparations for treating diabetes; pharmaceutical preparations for treating heatstroke; pharmaceutical preparations for treating malignant tumors; pharmaceutical preparations for treating metabolic disorders; pharmaceutical preparations for treating peripheral nervous system disorders; pharmaceutical preparations for use as immunosuppressive agents; pharmaceutical preparations for use in chemotherapy; pharmaceutical preparations for use in oncology; pharmaceutical preparations for use in organ transplantation; pharmaceutical preparations for use in tissue transplantation; pharmaceutical preparations for neurological conditions within the area of neurological intensive care; pharmaceutical preparations for the prevention of metabolicneurologicalcardiovascular and musculoskeletal diseasescancerdiabetesNASHmitochondrial diseases and rare diseases; pharmaceutical preparations for the treatment of metabolicneurologicalcardiovascular and musculoskeletal diseasescancerdiabetesNASHmitochondrial diseases and rare diseases; medical and veterinary preparations for metabolicneurologicalcardiovascular and musculoskeletal diseasescancerdiabetesNASHmitochondrial diseases and rare diseases; phosphates for pharmaceutical purposes; phosphates for veterinary purposes; medical plasters; medical dressings; potassium salts for medical purposes; potassium salts for veterinary purposes; preparations for destroying vermin; quinine for medical purposes; quinine for veterinary purposes; mineral salts for medical purposes; sanitary preparations for medical purposes; sanitary preparations for veterinary purposes; slimming pills being medical preparations for slimming purposes; sodium salts for medical purposes; sodium salts for veterinary purposes; sulfonamide preparations; tinctures being medicinal drinks for medical purposes; tinctures being medicinal drinks for veterinary purposes; tonics being medicinal drinks; tonics being medicinal drinks for medical use; tonics being medicinal drinks for veterinary use; vaccines; vaccines for human use; veterinary vaccines; drugs and pharmaceutical preparations for acute and chronic neurological diseases and conditions including preventive treatment; diagnostic agentspreparations and substances for medical purposes
Classe 9
Chromatography apparatus for laboratory use; DNA chips; electrodes for laboratory research
Classe 10
Blood testing apparatus; electrodes for medical use; probes for medical purposes; probes for veterinary purposes; electrodes for veterinary usemedical electrodes
Classe 42
Analysis of human tissues for medical research; bacteriological analysis and consultation relating thereto; biochemical research; biological analysis; scientific biological laboratory services; biological research and analysis; biological researchmedical research and clinical research in the fields of metabolicneurologicalcardiovascular and musculoskeletal diseasescancerdiabetesNASHmitochondrial diseases and rare diseases; biological sample analysis for scientific and medical research purposes; biological samplesblood or other bodily fluids analysis services for scientific and medical research purposes; biotechnology research; blood analysis services; blood analysis services for scientific and medical research purposes; chemical analysis and research; chemical research and analysis services; chemistry consultancy services; clinical research in the fields of metabolicneurologicalcardiovascular and musculoskeletal diseasescancerdiabetesNASHmitochondrial diseases and rare diseases; clinical research and trials for others in the fields of metabolicneurologicalcardiovascular and musculoskeletal diseasescancerdiabetesNASHmitochondrial diseases and rare diseases; scientific researchconducting clinical trials for others; conducting clinical trials being scientific research for others; conducting clinical trials for others; conducting clinical trials for pharmaceutical products for others; conducting early evaluations in the field of new pharmaceuticals; consultancy in the field of cosmeticsconsultancy in connection with the quality inspectionresearch and development of cosmetic products and medicated cosmetic products; consultancy in the field of sanitary research for medical purpose; consultancy in pharmaceuticalpharmacogeneticsmedical chemistryveterinary research; consultancy services in the field of biological research; consultancy services in the field of biotechnology; consulting on pharmacogenetics in the nature of pharmaceutical consultation; cosmetics research; cosmetics research and analysis services; cosmetics research services and laboratory analysis services in the field of cosmetics; design and development of computer hardware and software; design and development of diagnostic apparatus and instruments for medical use; design and development of medical diagnostic apparatus and instruments; developmenttesting and consultancy services in the fields of biotechnology researchpharmaceutical researchmedical researchveterinary medicine researchchemistry researchbiology researchpharmacogenetics research; DNA analysis for scientific and medical research purposes; drug and pharmaceutical discoverytesting and development services; drug discovery services; industrial analysis and research services in the fields of metabolicneurologicalcardiovascular and musculoskeletal diseasescancerdiabetesNASHmitochondrial diseases and rare diseases; laboratory research services relating to pharmaceuticals; medical and veterinary product research and development and consultancy related thereto; medical laboratory services; medical research; pharmaceutical product evaluation; pharmaceutical products development; pharmaceutical research and development; pharmaceutical research services; providing information in connection with all the aforementioned services; providing medical and veterinary testing services in the field of research relating to medicinesdrug discoverydrug development and drug screeningconsultancy related thereto; research and development in the field of biotechnology; biochemical research and development of microorganisms and cells; research and development in the pharmaceutical and biotechnology fields; scientific research and development services; research and testing in the fields of metabolicneurologicalcardiovascular and musculoskeletal diseasescancerdiabetesNASHmitochondrial diseases and rare diseases; research of pharmaceuticals; research relating to biotechnology; research relating to pharmaceuticals; researchdevelopmenttesting servicesconsultancy related theretoin the fields of biotechnology productspharmaceutical productssanitary productsmedical productsveterinary productschemistry productsbiology productspharmacogenetics products; researchdevelopmenttesting servicesconsultancy related theretoin the fields of biotechnologypharmaceuticalssanitary productschemistrybiology and pharmacogenetics; researchdevelopmenttesting and consultancy services in the fields of biotechnology productspharmaceutical productsmedical productssanitary productsveterinary productschemistry productsbiology productspharmacogenetics products; researchdevelopmenttestingscientific consultancy services in the fields of biotechnology productspharmaceutical productsmedical productssanitary productsveterinary productschemistry productsbiology productspharmacogenetics products; research in the field of environmental protection; researchtesting and development of sanitarypharmaceuticalmedicalmedicinal chemicalveterinary preparations; researchtesting and development of biotechnicalbiological preparations; researchtesting and development in the field of diagnostic preparations; researchtesting and development of diagnostic preparations for medical purpose; scientific analysis in the fields of metabolicneurologicalcardiovascular and musculoskeletal diseasescancerdiabetesNASHmitochondrial diseases and rare diseases; scientific and technological servicesscientific researchanalysis and testing in the fields of metabolicneurologicalcardiovascular and musculoskeletal diseasescancerdiabetesNASHmitochondrial diseases and rare diseasesresearch and design relating thereto; scientific laboratory services; scientific research; scientific research relating to cosmetics; testing of pharmaceuticals; blood toxicity analysis; toxicity testing in the nature of drug screening for research purposes; veterinary laboratory services
Classe 44
Analysis of human serum for medical treatment; analysis of human tissues for medical treatment; consultancy in the field of cosmeticsconsultancy in connection with the selection of cosmetic products and medicated cosmetic products; consultancy in the medical fieldpharmacogenetics; consultancy in the medical fieldother than dentistry; drug screening for medical purposes; health care; health care services; hygienic and beauty care for human beings or animals; medical and surgical diagnostic testing services; medical consultancy in the field of pharmacogenetics; medical consultancy services; medical diagnostic services in the nature of performing diagnosis of diseases; medical services; medical testing for diagnostic or treatment purposes; pharmaceutical consultancy services; providing information in connection with all the aforementioned services; rental of ultrasonic diagnostic apparatus; veterinary consultancy services; veterinary services
Publicações
Histórico de despachos e eventos da marca no USPTO.
30 publicações encontradas
NREP
NEW REPRESENTATIVE AT IB RECEIVED
08/05/2025
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
18/02/2025
NREP
NEW REPRESENTATIVE AT IB RECEIVED
01/01/2023
NREP
NEW REPRESENTATIVE AT IB RECEIVED
28/10/2021
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
23/10/2020
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
26/06/2020
FICS
FINAL DISPOSITION NOTICE SENT TO IB
09/06/2020
FIMP
FINAL DISPOSITION PROCESSED
09/06/2020
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
18/05/2020
R.PR
REGISTERED-PRINCIPAL REGISTER
18/02/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/12/2019
PUBO
PUBLISHED FOR OPPOSITION
03/12/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
13/11/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
31/10/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
16/09/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
16/09/2019
ALIE
ASSIGNED TO LIE
12/09/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/09/2019
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
06/09/2019
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
06/09/2019
RFNT
REFUSAL PROCESSED BY IB
05/07/2019
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
18/06/2019
RFRR
REFUSAL PROCESSED BY MPU
17/06/2019
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
30/05/2019
CNRT
NON-FINAL ACTION WRITTEN
29/05/2019
MAFR
APPLICATION FILING RECEIPT MAILED
14/05/2019
DOCK
ASSIGNED TO EXAMINER
10/05/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/05/2019
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
09/05/2019
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace NP ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.